Stephen Doster

  • Headshot of Wenbiao Chen.

    Immune cells drive beta cell loss in Type 2 diabetes

    Obesity and overnutrition increase the risk of Type 2 diabetes through several mechanisms. One of these is through loss of the insulin-producing beta cells of the pancreatic islet.  Wenbiao Chen, PhD, and colleagues previously have shown that overnutrition stressed the endoplasmic reticulum, the part of the beta… Read More

    Sep. 8, 2022

  • Vanderbilt University

    John Wilson to use $3 million grant to develop technology to help cancer patients better fight disease

    John Wilson, associate professor of chemical and biomolecular engineering at Vanderbilt University, has received a $3 million grant from the National Cancer Institute to develop technology that seeks to boost a person’s immune system to better fight cancer. Wilson is the Principal Investigator of the five-year grant. He specializes in… Read More

    Sep. 7, 2022

  • Vanderbilt University

    Alissa Weaver & Matthew Tyska named 2022 ASCB Fellows!

    Alissa Weaver, Professor and Cornelius Vanderbilt Chair, Vanderbilt University, and Matthew Tyska, Cornelius Vanderbilt Professor, Vanderbilt University have been named 2022 ASCB Fellows. “The 2022 ASCB Fellows are individuals who have contributed broadly and significantly to the cell biology community and to the Society. We honor their scientific achievement and their… Read More

    Sep. 2, 2022

  • New faculty Nancy Carrasco - Molecular Physiology, in her lab at Light Hall for Vanderbilt Magazine.

    Nancy Carrasco Named a 2023 2023 Biophysical Society Fellow

    Nancy Carrasco was recently named a 2023 Biophysical Society Fellow “for her broad-reaching studies of the sodium/iodide transporter including cloning and structure determination together with its roles in physiology and disease, and her impressive service to the Biophysics community.” The Biophysical Society is delighted to announce its 2023 Society Fellows. Read More

    Sep. 1, 2022

  • A simplified interface of a BioRender canvas with several people standing or sitting around the laptop, clicking on it or measuring things. The people are tiny and are not even as tall as the laptop screen itself.

    Basic Science researchers gain access to BioRender Premium

    By Emily Overway Thanks to a partnership between the Vanderbilt University School of Medicine Basic Sciences, the Office of the Vice Provost for Research, and the Office of the Provost, all graduate students, postdoctoral fellows, staff, and primary faculty in Basic Sciences will gain access to BioRender Premium… Read More

    Sep. 1, 2022

  • Vanderbilt University

    A new mechanism for lupus

    Systemic lupus erythematosus (SLE) — the most common form of lupus — is an autoimmune disease that causes widespread inflammation and tissue damage. David Harrison, MD, and colleagues have now described a new mechanism responsible for SLE.  They found that in humans with SLE and in two… Read More

    Sep. 1, 2022

  • Vanderbilt University

    Curriculum Revision Builds a Foundation for Ph.D. Students to Succeed

    An essential component of a graduate student’s training is the first-year coursework, which fosters the skills needed to be an independent researcher, such as critical literature analysis, the ability to understand the current state of a given field, and hypothesis generation. In the spring of 2020, a committee comprising faculty… Read More

    Aug. 30, 2022

  • Vanderbilt University

    Basic Sciences faculty and staff join Vanderbilt Leadership Academy, Vanderbilt Leadership Enrichment classes

    Alyssa Hasty (associate dean for faculty, School of Medicine Basic Sciences), Claudia Paz (chief business officer, School of Medicine Basic Sciences), Tiffany Lawrence Givens (director of human resources, Basic Sciences Dean’s Office, School of Medicine), and Kimberly D. Turner (assistant dean of administrative operations, School of Medicine Basic Sciences) have been named to… Read More

    Aug. 25, 2022

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    COVID antibody research conducted at VUMC lands national award

    A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals, and which was optimized and developed by the global pharmaceutical company AstraZeneca, has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine. Now… Read More

    Aug. 25, 2022

  • Vanderbilt University

    New high-tech biobank safeguards critical specimens

    Vanderbilt University Medical Center has opened a state-of-the-art automated biobanking system that can store as many as 10 million biospecimens, including blood and body fluids, tissue, and genetic and protein material, at temperatures down to minus 80 degrees Celsius. The “BioStore” was purchased from its manufacturer, Massachusetts-based Azenta Life… Read More

    Aug. 25, 2022